CNTA

14.38

1.44% -0.21

After Hours: 14.38

Centessa Pharmaceuticals Plc Adr (CNTA)

Overview News Price History Option Chain Financials Discussions Forecast

Centessa Pharmaceuticals Plc Adr stock is traded at $14.38, with a volume of 855.29K. It is down -1.44% in the last 24 hours and down -7.52% over the past month.

Previous Close:

$14.59

Open:

$14.74

24h Volume:

855.29K

Relative Volume:

1.05

Market Cap:

$1.93B

Revenue:

Net Income/Loss:

$-151.09M

P/E Ratio:

-9.2179

EPS:

-1.56

Net Cash Flow:

$-160.51M

1W Performance:

-13.53%

1M Performance:

-7.52%

6M Performance:

-10.07%

1Y Performance:

+27.26%

1-Day Range:

$13.75

$14.89

1-Week Range:

$13.75

$16.62

52-Week Range:

$7.75

$19.09

Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile

Name

Centessa Pharmaceuticals Plc Adr

Sector

Healthcare (1164)

Industry

Biotechnology (681)

Phone

44 7391 789784

Address

3RD FLOOR, ALTRINCHAM, CHESHIRE

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CNTA's Discussions on Twitter

Compare CNTA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CNTA Centessa Pharmaceuticals Plc Adr	14.38	1.93B	0	-151.09M	-160.51M	-1.56
VRTX Vertex Pharmaceuticals Inc	484.82	131.41B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	634.23	72.26B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	591.87	36.10B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	270.02	35.03B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	272.17	28.24B	3.81B	-644.79M	-669.77M	-6.24

Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-07-25	Initiated	TD Cowen	Buy
Sep-20-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-19-24	Initiated	B. Riley Securities	Buy
Jul-18-24	Initiated	Oppenheimer	Outperform
Nov-15-23	Upgrade	Jefferies	Hold → Buy
Oct-26-23	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Jun-21-23	Initiated	Evercore ISI	Outperform
Jun-12-23	Initiated	Guggenheim	Buy
Mar-17-23	Initiated	SVB Securities	Outperform
Aug-12-22	Downgrade	Morgan Stanley	Overweight → Underweight
Jun-17-22	Initiated	BMO Capital Markets	Outperform
Jun-03-22	Downgrade	Jefferies	Buy → Hold
Feb-11-22	Initiated	Goldman	Neutral

View All

Centessa Pharmaceuticals Plc Adr Stock (CNTA) Latest News

07:46 AM

Piper Sandler Initiates Centessa Pharmaceuticals at Overweight With $38 Price Target - MarketScreener

07:46 AM

Mar 26, 2025

Centessa Pharmaceuticals chief business officer sells $163,386 in stock - Investing.com

Mar 26, 2025

Mar 21, 2025

Centessa Pharmaceuticals CEO sells shares worth $918,060 By Investing.com - Investing.com South Africa

Mar 21, 2025

Centessa Pharmaceuticals CEO sells shares worth $918,060 - Investing.com India

Mar 21, 2025

Mar 19, 2025

Centessa Pharmaceuticals CAO sells shares worth $120,205 By Investing.com - Investing.com South Africa

Mar 19, 2025

Centessa Pharmaceuticals CAO sells shares worth $120,205 - Investing.com India

Mar 19, 2025

Mar 03, 2025

Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA)’s Stock Boosts 3.25%, But It May Be A Worthy Investment - Stocks Register

Mar 03, 2025

Feb 25, 2025

Ratios Revealed: Decoding Centessa Pharmaceuticals plc ADR (CNTA)’s Financial Health - The Dwinnex

Feb 25, 2025

Feb 18, 2025

Hemophilia Market Insights: Key Trends and Developments Across Different Types of Hemophilia | DelveInsight - GlobeNewswire Inc.

Feb 18, 2025

Feb 11, 2025

Centessa Pharmaceuticals officer sells shares worth $588,943 - Investing.com India

Feb 11, 2025

Feb 10, 2025

Aegon Ltd (AEG) looking to reclaim success with recent performance - SETE News

Feb 10, 2025

Adversity is less terrifying than hope: Wayfair Inc (W) - SETE News

Feb 10, 2025

Perhaps timely catching Autolus Therapeutics plc ADR (AUTL) would be a good idea - SETE News

Feb 10, 2025

Taking the lead: Centessa Pharmaceuticals plc ADR (CNTA) - SETE News

Feb 10, 2025

Feb 07, 2025